Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Añadir filtros








Tipo de estudio
Intervalo de año
1.
Braz. j. infect. dis ; 20(1): 26-32, Jan.-Feb. 2016. tab, graf
Artículo en Inglés | LILACS | ID: lil-776469

RESUMEN

Abstract Increased serum CA 19-9 levels in patients with nonmalignant diseases have been investigated in previous reports. This study evaluates the clinical significance of serum CA 19-9 elevation in pulmonary nontuberculous mycobacterial disease and pulmonary tuberculosis. The median CA 19-9 level was higher in patients with pulmonary nontuberculous mycobacterial disease than in patients with pulmonary tuberculosis (pulmonary nontuberculous mycobacterial disease: 13.80, tuberculosis: 5.85, p < 0.001). A multivariate logistic regression analysis performed in this study showed that Mycobacterium abscessus (OR 9.97, 95% CI: 1.58, 62.80; p = 0.014) and active phase of pulmonary nontuberculous mycobacterial disease (OR 12.18, 95% CI: 1.07, 138.36, p = 0.044) were found to be risk factors for serum CA 19-9 elevation in pulmonary nontuberculous mycobacterial disease. The serum CA 19-9 levels showed a tendency to decrease during successful treatment of pulmonary nontuberculous mycobacterial disease but not in pulmonary tuberculosis. These findings suggest that CA 19-9 may be a useful marker for monitoring therapeutic responses in pulmonary nontuberculous mycobacterial disease, although it is not pulmonary nontuberculous mycobacterial disease-specific marker.


Asunto(s)
Adulto , Anciano , Anciano de 80 o más Años , Femenino , Humanos , Masculino , Persona de Mediana Edad , /sangre , Enfermedades Pulmonares/sangre , Infecciones por Mycobacterium no Tuberculosas/clasificación , Antibacterianos/administración & dosificación , Biomarcadores/sangre , Quimioterapia Combinada , Enfermedades Pulmonares/tratamiento farmacológico , Enfermedades Pulmonares/microbiología
2.
Braz. j. microbiol ; 41(1): 227-234, Jan.-Mar. 2010. graf
Artículo en Inglés | LILACS | ID: lil-531756

RESUMEN

Biofouling of membranes demands costly periodic cleaning and membrane replacement. A sustainable and environmentally friendly solution for maintenance is not available and would be of great interest for many purposes including economical. As complex biofilm formation by environmental strains is the major cause of biofouling and biofilm formation in most cases are controlled by N-Acylhomoserine lactone (AHL)mediated Quorum Sensing (QS). An effort was made to understand the appropriateness of 2(5H)-furanone, to use against biofouling of membranes. QS inhibition activity by 2(5H)-furanone was studied using bioindicator strains and known AHLs of different acyl chain lengths. The biofilm inhibition was studied by growth analysis on polystyrene plate of Aeromonas hyrdrophila, an environmental biofilm strain isolated from a bio-fouled reverse osmosis (RO) membrane. Results showed a QS inhibition activity against a wide range of AHLs and also biofilm formation by 2(5H)-furanone, which is believed to act as a potential quorum inhibition agent in a bacterial biofilm community.


Asunto(s)
Biopelículas/crecimiento & desarrollo , Filtros de Membrana/análisis , Furanos/análisis , Furanos/aislamiento & purificación , Lactonas/análisis , Poliestirenos/análisis , Poliestirenos/aislamiento & purificación , Métodos , Métodos , Purificación del Agua
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA